Susceptibility of enterohaemorrhagicEscherichia colito azithromycin in France and analysis of resistance mechanisms | Zendy

Christelle Jost | Zendy; Philippe Bidet | Zendy; Thibault Carrère | Zendy; Patricia MarianiKurkdjian | Zendy; Stéphane Bonacorsi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Susceptibility of enterohaemorrhagicEscherichia colito azithromycin in France and analysis of resistance mechanisms

Author(s) -

Christelle Jost,

Philippe Bidet,

Thibault Carrère,

Patricia MarianiKurkdjian,

Stéphane Bonacorsi

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv477

Subject(s) - azithromycin , microbiology and biotechnology , etest , plasmid , biology , antibiotic resistance , antibiotics , serotype , virology , macrolide antibiotics , gene , erythromycin , genetics

Antibiotic therapy is not recommended during enterohaemorrhagic Escherichia coli (EHEC) infection. However, the potential benefit of azithromycin has recently been described. This study was conducted to evaluate the macrolide susceptibility of EHEC isolates from France and to analyse the mechanisms of resistance to azithromycin in EHEC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research